IUIS relationship with the World Health Organization

September 15, 2017

 

IUIS has long had an informal relationship with the World Health Organisation (WHO). In 2017, this relationship was formalized according to WHO guidelines. The goal of the collaboration is to advance WHO’s work on quality, safety and efficacy of medical biological products with IUIS providing relevant expert immunology knowledge. Our new relationship involves planned contributions from IUIS and its members.

Specifically, we will work together on the WHO Programme Area: access to medicines and health technologies and strengthening regulatory capacity.

 

IUIS will provide support and knowledge in determining norms and standards for biologicals, especially vaccines, and scientific input on nomenclature of immunology molecules. We also support educational activities and communication to strengthen expertise in immunology.

 

We are grateful to Ivana Knezevic, who is our WHO liaison and has helped us immensely in creating this collaboration. We look forward to some exciting outcomes in the next three years.

More News

The British Immunological Society launches the “Celebrate Vaccines” campaign on March 26

March 25, 2020

CALL FOR EXPERTS: IUIS-Frontiers in Immunology Webinar Series on COVID-19

March 13, 2020

Modified tuberculosis vaccine as therapy against bladder cancer

March 5, 2020

ASI Invite IUIS Members to Become a Member

February 26, 2020Australian and New Zealand Society for Immunology

Coronavirus disease (COVID-19)

February 24, 2020

Early Career Research Prize in Vaccinology R&D – Call for Applications!

February 10, 2020

IUIS-FAIS-SAI-AAA Immuno Algeria 2020: Challenge of Allergy in the molecular era

January 31, 2020

Congratulations to winners of the GECD Travel Award 2020

January 10, 2020

IUIS-AAI travel fellowships 2020

December 16, 2019Gender Equality and Career Development Committee (GEC), Education Committee (EDU)